Large animal models in translational retinal research

Webinar| June 19| Noon - 1:30pm ET

  • Member/Member-in-training price — $0
  • Nonmember/Nonmember-in-training price — $15

Audience: Vision scientists, researchers interested in using large animals in translational retinal research. 

Summary: The use of animal models is vital in retinal research, including the better understanding of disease mechanisms as well as the development and pre-clinical testing of novel therapies. A wide variety of animal models are used in retinal research, but mice and rats form the majority. Although rodent models have greatly improved our understanding of the pathogenesis of human retinal diseases and have proven to be useful for discovering targets for therapeutic drugs, they sometimes do not mimic the human disorders completely. In contrast, major advances in this area have been made in recent years when using large animal models such as monkeys, dogs, cats and pigs. In this Workshop, which is organized by the ARVO Animals in Research Committee, the audience will be updated on the application and translational aspects of the use of large animal models in retinal research.

This webinar is hosted by ARVO's Animals in Research Committee (ARC). A certificate of attendance will be available to attendees upon request (email

Organizers: Meredith Gregory-Ksander, PhD; Christophe P. Ribelayga, PhD; Yutao Liu, PhD; Rupesh Singh, PhD.

Register now button



Canine models of inner and outer retinal disorders – a brief overview

Andras KomaromyAndras Komaromy, DVM, PHD (Michigan State University)

The use of pigs for studying and treating eye disease

Maureen McCallMaureen McCall, PhD (University of Louisville)

Companion dogs as translational models of retinal aging and risk factors

Freya MowatFreya Mowat, DVM, PHD (University of Wisconsin-Madison) 

Retinal circuits in health and disease: Insights from non-human primate models

Teresa PuthusseryTeresa Puthussery, OD, PHD (University of California-Berkeley)

Use of cat and dog models with spontaneous IRDs for development of translational therapies

Simon Peterson JonesSimon Petersen-Jones, DVM, PhD (Michigan State University)



*Presenters and presentations are subject to change.